Monte Rosa Therapeutics Statistics
Total Valuation
GLUE has a market cap or net worth of $901.76 million. The enterprise value is $360.30 million.
| Market Cap | 901.76M |
| Enterprise Value | 360.30M |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GLUE has 85.31 million shares outstanding. The number of shares has increased by 17.46% in one year.
| Current Share Class | 85.31M |
| Shares Outstanding | 85.31M |
| Shares Change (YoY) | +17.46% |
| Shares Change (QoQ) | +7.03% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 80.47% |
| Float | 54.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.82 |
| Forward PS | 22.09 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 1.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.32, with a Debt / Equity ratio of 0.07.
| Current Ratio | 10.32 |
| Quick Ratio | 10.24 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.30% and return on invested capital (ROIC) is -23.03%.
| Return on Equity (ROE) | -35.30% |
| Return on Assets (ROA) | -16.29% |
| Return on Invested Capital (ROIC) | -23.03% |
| Return on Capital Employed (ROCE) | -23.73% |
| Weighted Average Cost of Capital (WACC) | 11.40% |
| Revenue Per Employee | $406,503 |
| Profits Per Employee | -$757,064 |
| Employee Count | 173 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GLUE has paid $1.04 million in taxes.
| Income Tax | 1.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.13% in the last 52 weeks. The beta is 1.38, so GLUE's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -14.13% |
| 50-Day Moving Average | 11.70 |
| 200-Day Moving Average | 17.05 |
| Relative Strength Index (RSI) | 45.00 |
| Average Volume (20 Days) | 1,504,222 |
Short Selling Information
The latest short interest is 20.66 million, so 24.22% of the outstanding shares have been sold short.
| Short Interest | 20.66M |
| Short Previous Month | 19.69M |
| Short % of Shares Out | 24.22% |
| Short % of Float | 37.93% |
| Short Ratio (days to cover) | 14.00 |
Income Statement
In the last 12 months, GLUE had revenue of $70.33 million and -$130.97 million in losses. Loss per share was -$1.35.
| Revenue | 70.33M |
| Gross Profit | -63.38M |
| Operating Income | -150.82M |
| Pretax Income | -129.94M |
| Net Income | -130.97M |
| EBITDA | -142.64M |
| EBIT | -150.82M |
| Loss Per Share | -$1.35 |
Balance Sheet
The company has $577.73 million in cash and $36.27 million in debt, with a net cash position of $541.46 million or $6.35 per share.
| Cash & Cash Equivalents | 577.73M |
| Total Debt | 36.27M |
| Net Cash | 541.46M |
| Net Cash Per Share | $6.35 |
| Equity (Book Value) | 496.21M |
| Book Value Per Share | 5.81 |
| Working Capital | 578.02M |
Cash Flow
In the last 12 months, operating cash flow was -$165.48 million and capital expenditures -$8.92 million, giving a free cash flow of -$174.39 million.
| Operating Cash Flow | -165.48M |
| Capital Expenditures | -8.92M |
| Depreciation & Amortization | 8.18M |
| Net Borrowing | n/a |
| Free Cash Flow | -174.39M |
| FCF Per Share | -$2.04 |
Margins
Gross margin is -90.12%, with operating and profit margins of -214.46% and -186.24%.
| Gross Margin | -90.12% |
| Operating Margin | -214.46% |
| Pretax Margin | -184.77% |
| Profit Margin | -186.24% |
| EBITDA Margin | -202.83% |
| EBIT Margin | -214.46% |
| FCF Margin | n/a |
Dividends & Yields
GLUE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.46% |
| Shareholder Yield | -17.46% |
| Earnings Yield | -12.75% |
| FCF Yield | -19.34% |
Analyst Forecast
The average price target for GLUE is $26.88, which is 154.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.88 |
| Price Target Difference | 154.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | -4.78% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |